Research Projects
Projects conducted within the framework of the current contract with NICE / NIHR
Warwick Evidence receives funding from the NIHR HTA Programme and the National Institute for Health and Care Excellence (NICE). The total allocated funding for the current contract running from April 2016 until April 2021 is £4,500,000. In the framework of their current contract with NICE, Warwick Evidence has been allocated the following projects:
Project number |
Project title |
Principal Investigator |
Start date |
| 13/65 |
ChondroCelect for cartilage defects of the knee [ID686] |
Norman Waugh / Hema Mistry | 01/06/15 |
| 13/74 | Multiple sclerosis - beta interferon and glatiramer acetate (review of TA32) [ID809] | G J Melendez-Torres | 05/01/16 |
| 14/206/11 | Lesinurad in combination with a xanthine oxidase inhibitor for previously treated chronic hyperuricaemia in gout [ID761] | James Mason | 28/01/16 |
| 15/69/07 | Ramucirumab with docetaxel after platinum chemotherapy for treating metastatic, non small cell lung cancer [ID838] | Aileen Clarke | 18/12/15 |
| 15/69/06 | Daclizumab for treating relapsing-remitting multiple sclerosis | Aileen Clarke | 05/04/16 |
| 15/17/03 | xTAG Gastrointestinal Pathogen Panel for the detection and identification of pathogens in gastroenteritis | James Mason | 04/12/15 |
| 16/56/22 | Ocrelizumab for treating primary progressive multiple sclerosis [ID938] | G. J. Melendez-Torres | 26/06/17 |
| 15/148/09 | Dapagliflozin in triple therapy regimens for treating type 2 diabetes [ID962] | Norman Waugh | 09/03/16 |
| 16/10/03 |
Biotin for primary and secondary progressive multiple sclerosis [ID919] |
G J Melendez-Torres | 02/12/16 |
| 16/10/11 |
Hema Mistry |
08/08/16 | |
| 14/189/02 | Dimethyl fumarate for treating moderate to severe plaque psoriasis (ID776) | James Mason | 03/11/16 |
| 16/54/01 | Glycerol phenylbutyrate for treating urea cycle disorders [ID942] | Aileen Clarke | 13/10/2016 |
| 16/54/06 | Recombinant human nerve growth factor for treating neurotrophic keratitis ID946 | Aileen Clarke | 18/01/2017 |
| 16/30/04 | Faecal calprotectin testing to monitor response to pharmacological treatment in patients with inflammatory bowel disease | Hema Mistry | 21/02/17 |
Please find a selection of completed projects for NICE / NIHR here.
Research projects conducted with other external funding
The researchers of Warwick Evidence also successfully apply for additional funding. Currently, the team works on the following projects:
Project Title |
Funding Body |
Value |
Date |
Investigators |
| ICARE4EU (Innovating care for people with multiple chronic conditions in Europe) | DG SANCO Second Public Health Programme | £ 30.000 | 2013-2016 | Dyakova, M, and Clarke, A |
| Improving health outcome for young people with long term conditions: the role of digital communication in current and future patient-clinician communication for NHS providers of specialist clinical services (the LYNCs study) |
NIHR: Health Services and Delivery Research Programme | 05.2014 - 02.2017 | Griffiths F, Stuart J, Cave J, Madan J, Sutcliffe P et al. |
|
| CLAHRC: Theme 3: Prevention and Detection | NIHR | £1,250,000 | 2014-2018 | Clarke, A |
| Chronic Headache Education and Self-management Study (CHESS). | NIHR Programme Grants for Applied Research | £1,989,949 | 60 months from 05/01/2015 | Underwood M, Mistry H. |
| Epidemiology of Communicable Disease Control Evidence Centre | PHE | £600,000 | 2015-2020 | Clarke A |
| LDC Staff Network Funding: Qualitative and Mixed Methods Interest Group | Warwick University Learning and Development Centre | £875.00 | Oct 2015 – Oct 2016 | Grove A, Tierney S, Johnson R |
| Development of a UK Evidence-Based Pathway for the Management of Chronic Constipation in Adults | NIHR PGfAR | £1,950,294 | 2013-2018 (60 months), | Knowles C, Emmanuel A, Vaizey C, Norton C, Gilbert D, Mason J, Sedgwick J, Cardozo L, Moss-Morris R, Scott M, Eldridge S, Taylor S, Yiannakou Y, Smalley L. |
| Improving the diagnosis and management of dementias of lewy body type in the NHS (DIAMAND-Lewy) | NIHR Programme Grant | £1,660,753 | 2013 – 2017 (60 months) | Brien J, Burn D, Thomas A, Bamford C, McKeith I, Taylor J, Allan L, James P, Deverill M, Finch T, Mason J, Docking |
| How can interventions integrating health and academic education in schools help prevent substance misuse and violence, and reduce health inequalities among young people? Systematic review and evidence synthesis | NIHR Evaluation, Trials and Studies | £217,442 | Jan 2016 – March 2018 | Bonell C (PI), Thomas J, Fletcher A, Campbell R, Melendez-Torres GJ |
| A Prospective Pilot Study of Home Monitoring in Adults with Cystic Fibrosis (HOME-CF). | NIHR Research for Patient Benefit | £275,025 | January 2016 for 27 months | Nash E, Mistry H |
| Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) - A pilot study to look at enhancing patient care improving patient outcomes and reducing NHS Costs. | NIHR Research for Patient Benefit. | £249,910 | April 2015 for 30 months | Thomas M, Mistry H |
| Bibliometric study of macular research in the UK | Macular Society | £5,000 | 2016 | Waugh N, Royle P |
| PEARL. Early Laser Treatment for Diabetic Eye Disease in China: A Pilot Randomized Trial | MRC Newton Programme. Trial Development Grant scheme of the Global Trials Initiative | £150,000 | 24 months from 01/09/2016 | Congdon N, Lois N, Waugh N, Mistry H |
| Diabetic Macular Oedema and Diode Subthreshold micropulse laser (DIAMONDS). | NIHR Health Technology Assessment | £1,004,147 | 50 months from 01/04/2016 | Lois N, Waugh N, Mistry H |
Please find a list of selected completed research projects here.